Conversely, factors associated with lower rejection rates include a longer time between transplantation and cancer diagnosis [23], the use of mTOR inhibitors, the maintenance of at least two immunosuppressive drugs at the time of ICPI initiation [32, 38], and deceased donor kidney transplantation [7]. Here, MTOR is linked to cancer.